A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Public ClinicalTrials.gov record NCT03432286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17 years of age for the preventive treatment of episodic migraine. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Study identification
- NCT ID
- NCT03432286
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 533 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2018 (Actual)
- Primary completion
- Nov 14, 2025 (Actual)
- Completion
- Nov 2026 (Estimated)
- Last update posted
- Jan 26, 2026
2018 – 2026
United States locations
- U.S. sites
- 38
- U.S. states
- 22
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rehabilitation & Neurological Services | Huntsville | Alabama | 35805 | — |
| 21st Century Neurology, a Division of Xenoscience, Inc. | Phoenix | Arizona | 85004 | — |
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | — |
| Center for Neurosciences | Tucson | Arizona | 85718 | — |
| Miller Children's & Women's Hospital Long Beach | Long Beach | California | 90806 | — |
| Wr-McCr, Llc | San Diego | California | 92108 | — |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | — |
| Clinical Neuroscience Solutions, Inc. dba CNS Healthcare | Jacksonville | Florida | 32256 | — |
| University of Miami Don Suffer Clinical Research Building | Miami | Florida | 33136 | — |
| Ezy Medical Research | Miami Lakes | Florida | 33015 | — |
| Clinical Neuroscience Solutions | Orlando | Florida | 32801 | — |
| Avanza Medical Research Center | Pensacola | Florida | 32503 | — |
| USF Health | Tampa | Florida | 33612 | — |
| Premiere Research Institute at Palm Beach Neurology | West Palm Beach | Florida | 33407 | — |
| Clinical Integrative Research Center of Atlanta, LLC | Atlanta | Georgia | 30328 | — |
| Meridian Clinical Research, LLC | Savannah | Georgia | 31406 | — |
| Medical Research Partners | Ammon | Idaho | 83406 | — |
| Elite Clinical Trials | Blackfoot | Idaho | 83221 | — |
| Northwest Clinical Trials | Boise | Idaho | 83704 | — |
| Inpatient Pharmacy | Hoffman Estates | Illinois | 60169 | — |
| University of Kentucky Chandler Medical Center | Lexington | Kentucky | 40536 | — |
| Pharmasite Research, Inc. | Baltimore | Maryland | 21208 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| MedVadis Research Corporation | Waltham | Massachusetts | 02451 | — |
| Minneapolis Clinic of Neurology - Burnsville Office | Burnsville | Minnesota | 55337 | — |
| Children Mercy Pediatric Clinical Research Unit | Kansas City | Missouri | 64108 | — |
| Dent Neurologic Institute | Amherst | New York | 14226 | — |
| Cohen Children's Northwell Health Physician Partners - Pediatric Neurology | New Hyde Park | New York | 11042 | — |
| Velocity Clinical Research at Raleigh Neurology | Raleigh | North Carolina | 27607 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| Providence Health & Services | Portland | Oregon | 97225 | — |
| UPMC Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | — |
| Office 18 | Pittsburgh | Pennsylvania | 15236 | — |
| Velocity Clinical Research, Providence | East Greenwich | Rhode Island | 02818 | — |
| Tribe Clinical Research, LLC | Greenville | South Carolina | 29607 | — |
| Pain and Headache Centers of Texas | Houston | Texas | 77054 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03432286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2026 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03432286 live on ClinicalTrials.gov.